My 10-share stock market portfolio for future growth

I have invested in a stock market portfolio of FTSE 350 shares that I expect to continue outperforming these indices over the medium to long term.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Inflation is rampant worldwide. Nevertheless, I believe that — in these difficult times — stock markets still offer the best investment hedge against inflation and excellent long-term return potential for carefully selected shares.

My portfolio

FTSEShareCodeMarket cap (£bn)IndustryYTD % performanceOne-year % performanceThree-year % performance
100AstraZenecaAZN175.8Pharmaceuticals24.1526.5147.23
250BeazleyBEZ3.5Insurance22.1345.240.00
100BunzlBNZL10.6Distribution, logistics-0.358.3342.82
250CapricornCNE0.7Oil, Gas Exploration25.9722.3942.21
100GlencoreGLEN64.9Mining & Trading30.3649.76108.12
250HuntingHTG0.5Energy Industry supplier68.4439.02-37.64
250IndiviorINDV2.1Pharmaceuticals12.0645.31377.45
250MediclinicMDC3.7Health55.5658.1246.85
250SercoSRP2.1Government Services32.1733.5621.93
100SSESSE19.4Power Generation2.512.3046.87
PortfolioAs at 31.8.2227.3033.0569.58

On an equal invested value basis, the portfolio has grown by 69.6% over the past three years (+19.2% per annum). While past performance is no guarantee of future performance, medium to long term I expect the overall portfolio to outperform the FTSE 100 and FTSE 250 indices.

One or two of the stocks may disappoint. Hence, I will actively manage the portfolio and substitute any stocks for which the prospects deteriorate.

AstraZeneca

A British-Swedish multinational pharmaceutical and biotechnology company. It was at the forefront of the rush to develop and distribute a vaccine for Covid-19. Its innovative medicines are used by millions of patients worldwide.

Beazley

A British parent company of worldwide insurance businesses. It underwrites a diverse book of insurance and reinsurance for clients and is a market leader in many of its chosen lines.

Bunzl

A British multinational distribution and outsourcing company. Over 50% of its business is in the food service and food retail sectors.

Capricorn Energy  (previously Cairn Energy)

A British oil and gas exploration and development company. Despite Britain’s net zero objectives, as green billionaire Elon Musk says, “civilization would crumble” if the world stops drilling for oil and gas.

Glencore

An Anglo-Swiss company. One of the world’s largest globally diversified natural resource businesses, being both a mining company and the world’s largest commodities trading firm.

Hunting

A British-based supplier to the oil and gas industry.

Indivior  

A global pharmaceutical company specialising in developing medicines to treat substance use disorders and serious mental illnesses.

Mediclinic International

An international private hospital group with hospitals in South Africa, Namibia, Switzerland and the United Arab Emirates.

Serco

A British contractor for the supply of Government services, primarily in the health, transport, justice, immigration, space, and defense sectors. 55% of the company’s revenue is generated outside the UK.

SSE

Formerly Southern and Scottish Energy, SSE is a multinational energy company that operates UK power stations and offshore wind farms and has a hydroelectric plant in Scotland.

Ian Benfield has positions in AstraZeneca, Beazley, Bunzl, Capricorn Energy, Glencore, Hunting, Indivior, Mediclinic, Serco and SSE. The Motley Fool UK has recommended Bunzl. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two elderly people relaxing in the summer sunshine Box Hill near Dorking Surrey England
Investing Articles

Forget the FTSE 100 and come back after summer? Here’s my plan!

With the FTSE 100 moving around in a volatile way, should our writer just forget all about it for a…

Read more »

Young female hand showing five fingers.
Investing Articles

£20,000 invested in a Stocks and Shares ISA 5 years ago could now be worth…

The last five years have been something of a roller coaster for the markets. How would £20k in a Stocks…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Stock market correction: a once-in-a-decade chance to build big passive income?

Ben McPoland takes a closer look at a high-yield passive income stock from the FTSE 250 that investors have been…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

In volatile markets, could National Grid dividends be a safe haven?

National Grid offers a dividend yield well above the FTSE 100 and aims to keep growing its payout per share.…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Down 25%, are Barclays shares simply too cheap to ignore?

Barclays shares have given up a chunk of their recent gains since the Middle East powder keg ignited. Should investors…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

How much would someone need in an ISA to target a £1,000 monthly second income?

Christopher Ruane explains how someone could use an empty Stocks and Shares ISA to target a four-figure monthly second income…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Are investors taking a big gamble chasing Rolls-Royce shares higher and higher?

With Rolls-Royce shares having fallen back from their peak, the temptation to see this as a buying opportunity must be…

Read more »

Cargo containers with European Union and British flags reflecting Brexit and restrictions in export and import
Investing Articles

Down 70%, is Fevertree Drinks a share to consider buying at 815p?

Fevertree reported its 2025 earnings today and the investors liked what they saw. So is this a share to consider…

Read more »